Haixia Zhou

机构：Jinan University, Wenzhou Medical University, Changsha Normal University, Soochow University, Second Affiliated Hospital & Yuying Children's Hospital of Wenzhou Medical University, Novavax (United States), National Clinical Research, First Affiliated Hospital of Soochow University · ORCID：0009-0001-5309-5715

发表论文 119 篇 · 总被引 2468 次 · h-index 22

代表论文

• Targeting p62 by sulforaphane promotes autolysosomal degradation of SLC7A11, inducing ferroptosis for osteosarcoma treatment (2024 · Redox Biology · 被引 28)
• Efficacy and safety of cladribine, low-dose cytarabine and venetoclax in relapsed/refractory acute myeloid leukemia: results of a pilot study (2024 · Blood Cancer Journal · 被引 20)
• Structural requirements for activity of Mind bomb1 in Notch signaling (2024 · Structure · 被引 9)
• Low expression of miR-182 caused by DNA hypermethylation accelerates acute lymphocyte leukemia development by targeting PBX3 and BCL2: miR-182 promoter methylation is a predictive marker for hypomethylation agents + BCL2 inhibitor venetoclax (2024 · Clinical Epigenetics · 被引 8)
• Single-dose avian influenza A(H5N1) Clade 2.3.4.4b hemagglutinin–Matrix-M® nanoparticle vaccine induces neutralizing responses in nonhuman primates (2025 · Nature Communications · 被引 4)
• A novel Quinazoline derivative exerts anti-tumor effects in non-small cell lung cancer through Wnt/β-catenin pathway inhibition (2025 · Bioorganic Chemistry · 被引 4)